Tag: Seqirus

Vaccine maker CSL’s massive year, massive profits

Australia’s largest company by market capitalisation, biotechnology manufacturer CSL has powered ahead in the first half of the financial year reporting a net profit after tax up 44 per...

CSL to build $800m Melbourne vaccine facility

16 November 2020 | by Peter Roberts

Biotechnology giant CSL will spend more than $800 million building a new vaccine manufacturing plant at the Melbourne Airport Business Park, with operations expected to start in 2026. The...

Tag: Seqirus

Vaccine maker CSL’s massive year, massive profits

CSL to build $800m Melbourne vaccine facility

Guide

Categories

SUBSCRIPTION ENQUIRIES

Privacy

EDITORIAL CONTACT

COMMERCIAL CONTACT

Search Filters Clear All

Tag: Seqirus